Cannabis Use, Medication Management and Adherence Among Persons Living with HIV
- 314 Downloads
Cannabis is used to relieve nausea, trigger weight gain, and reduce pain among adults living with HIV; however, the relationship between its use and medication adherence and management is unclear. Participants (N = 107) were from an ongoing cohort study of community-dwelling HIV+ adults, stratified by cannabis (CB) use: HIV+/CB+ (n = 41) and HIV+/CB− (n = 66). CB+ participants either tested positive in a urine toxicology screen for THC or had a self-reported history of regular and recent use. HIV-status was provided by physician results and/or biomarker assessment. Adherence was measured via the Morisky scale and medication management was assessed via the Medication Management Test-Revised. After adjusting for gender, we found no association between cannabis use group and adherence nor medication management. The amount of cannabis used was also not associated with measures of adherence and management. Preliminary findings suggest that cannabis use may not adversely influence medication adherence/management among adults living with HIV.
KeywordsCannabis Adherence Medication management HIV
This work was approved by Florida International University’s Institutional Review Board and was supported by Grants R01 DA031176 & R01 DA033156 (PI: Gonzalez) from the National Institute on Drug Abuse.
This study was funded by R01 DA031176 & R01 DA033156 (PI: Gonzalez) from the National Institute on Drug Abuse.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no competing interests.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Center for Behavioral Health Statistics and Quality. Behavioral health trends in the United States: results from the 2014 national survey on drug use and health. Rockville: 2015 Contract No.: HHS Publication No. SMA 15-4927.Google Scholar
- 2.Mimiaga MJ, Reisner SL, Grasso C, Crane HM, Safren SA, Kitahata MM, et al. Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health. 2013;103(8):1457–67.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(17):1556–63.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents: Department of Health and Human Services. 2016 [updated January 208, 2016]. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 2 Apr 2016.
- 25.Patton DE, Woods SP, Franklin D Jr, Cattie JE, Heaton RK, Collier AC, et al. Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV. AIDS Behav. 2012;16(8):2286–96.CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Wechsler D. Wechsler test of adult reading. San Antonio: Psychological Corporation; 2001.Google Scholar
- 39.Gonzalez R, Schuster RM, Mermelstein RJ, Vassileva J, Martin EM, Diviak KR. Performance of young adult cannabis users on neurocognitive measures of impulsive behavior and their relationship to symptoms of cannabis use disorders. J Clin Exp Neuropsychol. 2012;34(9):962–76.CrossRefPubMedPubMedCentralGoogle Scholar
- 42.First MB, Spitzer RL, BGibbon M, Williams JB. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. New York: New York State Psychiatric Institute; 2002.Google Scholar
- 45.Beck AT, Steer RA, Brown G. Manual for the beck depression inventory-II. Psychological Corporation: San Antonio; 1996.Google Scholar
- 46.Beck AT, Steer RA. Beck anxiety inventory manual. Psychological Corporation: San Antonio; 1993.Google Scholar